SUSAN GRIFFIN: Open Payments
NPI 1891744660 · WEST COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$976 in 43 payments from 21 companies in 2025. Trend: 2023 $1,002 · 2024 $1,154 · 2025 $976
Food & beverage: $959Education: $16
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 7 | $172 |
| Tandem Diabetes Care, Inc. | 4 | $91 |
| BETA BIONICS, INC. | 3 | $83 |
| Novo Nordisk Inc | 4 | $80 |
| Ascensia Diabetes Care Us Inc. | 3 | $59 |
| CeQur Corporation | 1 | $58 |
| Amgen Inc. | 3 | $58 |
| Insulet Corporation | 3 | $51 |
| Abbott Laboratories | 2 | $41 |
| ABBVIE INC. | 2 | $36 |
Products named: MINIMED 780G, t:slim X2 Insulin Pump with Control-IQ, iLet Bionic Pancreas, Ozempic, CeQur Simplicity, Omnipod, FREESTYLE LIBRE 3, TZIELD.
Industry payments across SC — which companies pay providers there.
